Pluripharm acquisition approved
30/07/2020
The purchase by Abacus Medicine of all shares in the Pluripharm Group has been completed successfully.
The deal was announced on 13 July 2020, and has now received the expected approval of the competition authorities of the Netherlands (Autoriteit Consument en Markt) and Germany (Bundeskartellamt).
The deal will allow Pluripharm to expand its offering to independent pharmacies and hospitals in the Netherlands, and ensure a high availability of medicine.
Pluripharm has 170 employees and will continue to operate under its current name.
Kontakt
Wir helfen gerne, also scheuen Sie sich bitte nicht, uns bei Fragen zu kontaktieren. Untenstehend finden Sie unsere Hauptniederlassungen, in denen unsere Mitarbeiter aus ganz Europa arbeiten.
Vesterbrogade 149
1620 Copenhagen V
Danmark
Wolfgang-Pauli-Gasse 5/1/1/6
A-1140 Wien
Österreich
Maglódi út 6
1106 Budapest
Hungary
Berliner Straße 8
D-16727 Velten
Deutschland
Abbey House
282 Farnborough Road
Farnborough GU14 7NA
England
Orionintie 5
02200 Espoo
Finland
12/14 Rond-Point des Champs-Elysées
Paris 75008, France
Diamantweg 4
1812 RC Alkmaar
Holland
